Complera Interactions
There are 564 drugs known to interact with Complera (emtricitabine/rilpivirine/tenofovir disoproxil), along with 10 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 215 are major, 347 are moderate, and 2 are minor.
- View all 564 medications that may interact with Complera
- View Complera alcohol/food interactions (2)
- View Complera disease interactions (10)
Most frequently checked interactions
View interaction reports for Complera (emtricitabine / rilpivirine / tenofovir disoproxil) and the medicines listed below.
- acyclovir
- Adderall (amphetamine / dextroamphetamine)
- Ambien (zolpidem)
- amlodipine
- Aspirin Low Strength (aspirin)
- atorvastatin
- BuSpar (buspirone)
- clonazepam
- Cymbalta (duloxetine)
- gabapentin
- ibuprofen
- Isentress (raltegravir)
- lisinopril
- lorazepam
- melatonin
- meloxicam
- metformin
- Metoprolol Tartrate (metoprolol)
- multivitamin
- Norvir (ritonavir)
- Odefsey (emtricitabine / rilpivirine / tenofovir alafenamide)
- Seroquel (quetiapine)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tivicay (dolutegravir)
- tramadol
- trazodone
- Truvada (emtricitabine / tenofovir disoproxil)
- Viagra (sildenafil)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Complera alcohol/food interactions
There are 2 alcohol/food interactions with Complera (emtricitabine / rilpivirine / tenofovir disoproxil).
Complera disease interactions
There are 10 disease interactions with Complera (emtricitabine / rilpivirine / tenofovir disoproxil) which include:
- hepatitis B
- hepatotoxicity
- hemodialysis
- renal dysfunction
- depression
- liver impairment
- renal impairment
- bone toxicity
- liver disease
- renal dysfunction
Report options
More about Complera (emtricitabine / rilpivirine / tenofovir disoproxil)
- Complera consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (60)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
